trial

Time and Virtual Reality in Schizophrenia and Bipolar Disorder

NCTId NCT04432116
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 120 (estimated)
Sponsored by Institut National de la Santé Et de la Recherche Médicale, France
Primary completion 2027-05-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
120 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Crossover
Masking
Single
Start
2021-08-12
Primary completion
2027-05-12
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
virtual reality 1virtual reality 2

Sponsors

Institut National de la Santé Et de la Recherche Médicale, FranceLead Sponsor

Sites

1 total
Strasbourg, France

Facts & assertions

4 sourced
Enrollment
120
Phase
NA
Primary Completion Date
2027-05-12
Status
RECRUITING
relationships
The graph out of here
drug
virtual reality 1
drug
virtual reality 2
drug
lead_sponsor
Institut National de la Santé Et de la Recherche Médicale, France
company
indication
Schizophrenia
indication
Bipolar Disorder
indication
Bipolar Disorder
indication